Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Polyps 2Hyperplasia 2Colorectal Neoplasms 2Weight Loss 1Psoriasis 1Osteoarthritis 1Colitis, Ulcerative 1Cholangiocarcinoma 1Carcinoma, Hepatocellular 1Cancer Cachexia 1Cachexia 1Breast Neoplasms 1Autoimmune Diseases 1Arthritis, Rheumatoid 1Anorexia 1Adenomatous Polyps 1Adenomatous Polyposis Coli 1

Interventions

Gemcitabine 39Cisplatin 24Oxaliplatin 15pembrolizumab 12Capecitabine 12Fluorouracil 9Leucovorin 7Albumin-Bound Paclitaxel 7lenvatinib 6Radiofrequency Ablation 6Panitumumab 6130-nm albumin-bound paclitaxel 6Irinotecan 5Bevacizumab 5durvalumab 4Taxes 4Nivolumab 4Hepatectomy 4Drug Therapy 4tremelimumab 3apatinib 3Radiosurgery 3Platinum 3Injections 3Floxuridine 3Cetuximab 31,2-diaminocyclohexaneplatinum II citrate 3trametinib 2spartalizumab 2sintilimab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Cholangiocarcinoma × Eicosapentaenoic Acid × Clear all
NCT00168987 2008-05-09

Influence of an Oral Nutritional Supplement Rich in Omega-3 Fatty Acids on Functional State and Quality of Life in Malnourished Patients With Gastroenterological Tumors

Charite University, Berlin, Germany

Phase 4 Completed
30 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Colorectal Neoplasms, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡